| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 263, Issue 5, 2358-2363, 02, 1988
LS Nielsen, GM Kellerman, N Behrendt, R Picone, K Dano and F Blasi
Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.
The iodinated Mr approximately equal to 15,000 amino-terminal fragment (ATF) of the urokinase-type plasminogen activator (u-PA) molecule bound specifically to the cell surface of all of seven cultured human tumor cell lines studied. Cross-linking of iodinated ATF to the cell surface using a bifunctional amino-reactive reagent followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography revealed with the four cell lines studied the occurrence of a single band migrating with an Mr of 70,000-75,000, indicating complex formation with an Mr of 55,000-60,000 u-PA receptor protein (u-PA-R). In the human monocyte cell line U937 cultivated in the presence of phorbol ester, the amount of complex was strongly increased, and a fraction of the complex had a slower electrophoretic mobility. Comparison between autoradiograms of reduced and unreduced samples suggests that u-PA-R consists of one polypeptide chain. Two forms of u-PA-R, which differed with respect to affinity to concanavalin A, were identified. u-PA-R retained its ability to bind to ATF after cell lysis, and it was purified approximately 2,200-fold from biosynthetically labeled U937 cells by affinity chromatography with proenzyme u-PA coupled to Sepharose. The purified Mr 55,000-60,000 protein was specifically bound and cross-linked to u-PA, proenzyme u-PA, and ATF, but not to tissue- type plasminogen activator or other unrelated proteins.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Yang, H. Avila, H. Wang, J. Trevino, G. E. Gallick, Y. Kitadai, T. Sasaki, and D. D. Boyd Plasticity in Urokinase-Type Plasminogen Activator Receptor (uPAR) Display in Colon Cancer Yields Metastable Subpopulations Oscillating in Cell Surface uPAR Density--Implications in Tumor Progression Cancer Res., August 15, 2006; 66(16): 7957 - 7967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gardsvoll, B. Gilquin, M. H. Le Du, A. Menez, T. J. D. Jorgensen, and M. Ploug Characterization of the Functional Epitope on the Urokinase Receptor: COMPLETE ALANINE SCANNING MUTAGENESIS SUPPLEMENTED BY CHEMICAL CROSS-LINKING J. Biol. Chem., July 14, 2006; 281(28): 19260 - 19272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kobayashi, T. Yagyu, T. Kondo, N. Kurita, K. Inagaki, S. Haruta, R. Kawaguchi, T. Kitanaka, Y. Sakamoto, Y. Yamada, et al. Suppression of Urokinase Receptor Expression by Thalidomide Is Associated with Inhibition of Nuclear Factor {kappa}B Activation and Subsequently Suppressed Ovarian Cancer Dissemination Cancer Res., November 15, 2005; 65(22): 10464 - 10471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kwon, C.-S. Yoon, W. Jeong, S. G. Rhee, and D. M. Waisman Annexin A2-S100A10 Heterotetramer, a Novel Substrate of Thioredoxin J. Biol. Chem., June 24, 2005; 280(25): 23584 - 23592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Boyd, H. Wang, H. Avila, N. U. Parikh, H. Kessler, V. Magdolen, and G. E. Gallick Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes in Vitro Colon Cancer Invasiveness Clin. Cancer Res., February 15, 2004; 10(4): 1545 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Coleman and J. L. Benach The Urokinase Receptor Can Be Induced by Borrelia burgdorferi through Receptors of the Innate Immune System Infect. Immun., October 1, 2003; 71(10): 5556 - 5564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, J. Hicks, P. Khanbolooki, S.-J. Kim, C. Yan, Y. Wang, and D. Boyd Transgenic Mice Demonstrate Novel Promoter Regions for Tissue-Specific Expression of the Urokinase Receptor Gene Am. J. Pathol., August 1, 2003; 163(2): 453 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Kreiling, J. C. Byrd, R. J. Deisz, I. F. Mizukami, R. F. Todd III, and R. G. MacDonald Binding of Urokinase-type Plasminogen Activator Receptor (uPAR) to the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor: CONTRASTING INTERACTIONS OF FULL-LENGTH AND SOLUBLE FORMS OF uPAR J. Biol. Chem., May 30, 2003; 278(23): 20628 - 20637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Boyd, S.-J. Kim, H. Wang, T. R. Jones, and G. E. Gallick A Urokinase-Derived Peptide (A6) Increases Survival of Mice Bearing Orthotopically Grown Prostate Cancer and Reduces Lymph Node Metastasis Am. J. Pathol., February 1, 2003; 162(2): 619 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.L.M. Lamfers, J.M. Grimbergen, M.C. Aalders, M.J. Havenga, M.R. de Vries, L.G.M. Huisman, V.W.M. van Hinsbergh, and P.H.A. Quax Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1 Circ. Res., November 15, 2002; 91(10): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Solberg, M. Ploug, G. Høyer–Hansen, B. S. Nielsen, and L. R. Lund The Murine Receptor for Urokinase-Type Plasminogen Activator Is Primarily Expressed in Tissues Actively Undergoing Remodeling J. Histochem. Cytochem., February 1, 2001; 49(2): 237 - 246. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. L. Coleman, J. A. Gebbia, and J. L. Benach Borrelia burgdorferi and Other Bacterial Products Induce Expression and Release of the Urokinase Receptor (CD87) J. Immunol., January 1, 2001; 166(1): 473 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Behrendt, O. N. Jensen, L. H. Engelholm, E. Mortz, M. Mann, and K. Dano A Urokinase Receptor-associated Protein with Specific Collagen Binding Properties J. Biol. Chem., January 21, 2000; 275(3): 1993 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Colman, B. A. Jameson, Y. Lin, D. Johnson, and S. A. Mousa Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis Blood, January 15, 2000; 95(2): 543 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gardsvoll, K. Dano, and M. Ploug Mapping Part of the Functional Epitope for Ligand Binding on the Receptor for Urokinase-type Plasminogen Activator by Site-directed Mutagenesis J. Biol. Chem., December 31, 1999; 274(53): 37995 - 38003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Allgayer, H. Wang, Y. Wang, M. M. Heiss, R. Bauer, O. Nyormoi, and D. Boyd Transactivation of the Urokinase-type Plasminogen Activator Receptor Gene through a Novel Promoter Motif Bound with an Activator Protein-2alpha -related Factor J. Biol. Chem., February 19, 1999; 274(8): 4702 - 4714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Koopman, J. Slomp, A. C. W. de Bart, P. H. A. Quax, and J. H. Verheijen Mitogenic Effects of Urokinase on Melanoma Cells Are Independent of High Affinity Binding to the Urokinase Receptor J. Biol. Chem., December 11, 1998; 273(50): 33267 - 33272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shetty and S. Idell A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L871 - L882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ploug, H. Rahbek-Nielsen, P. F. Nielsen, P. Roepstorff, and K. Dano Glycosylation Profile of a Recombinant Urokinase-type Plasminogen Activator Receptor Expressed in Chinese Hamster Ovary Cells J. Biol. Chem., May 29, 1998; 273(22): 13933 - 13943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. A. Quax, J. M. Grimbergen, M. Lansink, A. H. F. Bakker, M.-C. Blatter, D. Belin, V. W. M. van Hinsbergh, and J. H. Verheijen Binding of Human Urokinase-Type Plasminogen Activator to Its Receptor : Residues Involved in Species Specificity and Binding Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 693 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Plesner, N. Behrendt, and M. Ploug Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase-Type Plasminogen Activator Receptor, uPAR Stem Cells, November 1, 1997; 15(6): 398 - 408. [Abstract] [Full Text]
|
|
|
|
|
|
C. Sillaber, M. Baghestanian, R. Hofbauer, I. Virgolini, H. C. Bankl, W. Fureder, H. Agis, M. Willheim, M. Leimer, O. Scheiner, et al. Molecular and Functional Characterization of the Urokinase Receptor on Human Mast Cells J. Biol. Chem., March 21, 1997; 272(12): 7824 - 7832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Behrendt, E. Ronne, and K. Dano Domain Interplay in the Urokinase Receptor. REQUIREMENT FOR THE THIRD DOMAIN IN HIGH AFFINITY LIGAND BINDING AND DEMONSTRATION OF LIGAND CONTACT SITES IN DISTINCT RECEPTOR DOMAINS J. Biol. Chem., September 13, 1996; 271(37): 22885 - 22894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Bugge, T. T. Suh, M. J. Flick, C. C. Daugherty, J. R, H. Solberg, V. Ellis, K. Danø, and J. L. Degen The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility J. Biol. Chem., July 14, 1995; 270(28): 16886 - 16894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Shatos, T. Orfeo, J. M. Doherty, P. L. Penar, D. Collen, and K. G. Mann {alpha}-Thrombin Stimulates Urokinase Production and DNA Synthesis in Cultured Human Cerebral Microvascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1995; 15(7): 903 - 911. [Abstract] [Full Text]
|
|
|
|
|
|
C.-I W. Q. Y. and Charles S. Craik and C. I. Wang Isolation of a High Affinity Inhibitor of Urokinase-type Plasminogen Activator by Phage Display of Ecotin J. Biol. Chem., May 19, 1995; 270(20): 12250 - 12256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kobayashi, J. Gotoh, Y. Hirashima, M. Fujie, D. Sugino, and T. Terao Inhibitory Effect of a Conjugate between Human Urokinase and Urinary Trypsin Inhibitor on Tumor Cell Invasion in Vitro J. Biol. Chem., April 7, 1995; 270(14): 8361 - 8366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Young, S. V. Pizzo, and M. S. Stack A Plasma Membrane-associated Component of Ovarian Adenocarcinoma Cells Enhances the Catalytic Efficiency of Matrix Metalloproteinase-2 J. Biol. Chem., January 20, 1995; 270(3): 999 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Noda-Heiny, A. Daugherty, and B. E. Sobel Augmented Urokinase Receptor Expression in Atheroma Arterioscler. Thromb. Vasc. Biol., January 1, 1995; 15(1): 37 - 43. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. M. Mansuy, H. van der Putten, P. Schmid, M. Meins, F. M. Botteri, and D. Monard Variable and multiple expression of Protease Nexin-1 during mouse organogenesis and nervous system development Development, December 1, 1993; 119(4): 1119 - 1134. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
